Covidien received FDA approval of its Apollo Onyx delivery microcatheter for liquid embolization procedures of brain arteriovenous malformations. The device features a detachable tip, the first microcatheter available in the U.S. with such a function.
The Apollo Onyx was developed to improve catheter retrieval during Onyx LES embolization procedures and should help guarantee safe final results.
From the announcement:
The Apollo Onyx micro catheter enables physicians to choose the best catheter position for each procedure. It provides optimal navigability through complex distal anatomy as well as a proprietary detachable tip designed for easier catheter retrieval in challenging environments.
“Covidien is offering a new level of confidence for physicians by providing the only detachable tip micro catheter in the U.S.,” said Brett Wall, president, Neurovascular, Covidien. “The Apollo Onyx micro catheter has the potential to improve patient outcomes by safeguarding the neurovasculature during catheter retrieval.”
Press release: Covidien Neurovascular Micro Catheter Receives FDA Approval…